BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20069059)

  • 1. Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.
    Srisomsap C; Sawangareetrakul P; Subhasitanont P; Chokchaichamnankit D; Chiablaem K; Bhudhisawasdi V; Wongkham S; Svasti J
    J Biomed Biotechnol; 2010; 2010():437143. PubMed ID: 20069059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker.
    Verathamjamras C; Weeraphan C; Chokchaichamnankit D; Watcharatanyatip K; Subhasitanont P; Diskul-Na-Ayudthaya P; Mingkwan K; Luevisadpaibul V; Chutipongtanate S; Champattanachai V; Svasti J; Srisomsap C
    Int J Oncol; 2017 Jul; 51(1):269-280. PubMed ID: 28560424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of cholangiocarcinoma cell line.
    Srisomsap C; Sawangareetrakul P; Subhasitanont P; Panichakul T; Keeratichamroen S; Lirdprapamongkol K; Chokchaichamnankit D; Sirisinha S; Svasti J
    Proteomics; 2004 Apr; 4(4):1135-44. PubMed ID: 15048994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
    Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
    World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues.
    Kawase H; Fujii K; Miyamoto M; Kubota KC; Hirano S; Kondo S; Inagaki F
    J Proteome Res; 2009 Aug; 8(8):4092-103. PubMed ID: 19569727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Al-Bahrani R; Nagamori S; Leng R; Petryk A; Sergi C
    Pathol Oncol Res; 2015 Sep; 21(4):901-8. PubMed ID: 25740074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.
    Asayama Y; Taguchi Ki K; Aishima Si S; Nishi H; Masuda K; Tsuneyoshi M
    Liver; 2002 Feb; 22(1):43-50. PubMed ID: 11906618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.
    Shi Y; Deng X; Zhan Q; Shen B; Jin X; Zhu Z; Chen H; Li H; Peng C
    J Gastrointest Surg; 2013 Sep; 17(9):1584-91. PubMed ID: 23868055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
    Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
    Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.
    Chua-On D; Proungvitaya T; Techasen A; Limpaiboon T; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sungkhamanon S; Proungvitaya S
    Tumour Biol; 2016 Oct; 37(10):13659-13667. PubMed ID: 27473083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells.
    Christa L; Simon MT; Brezault-Bonnet C; Bonte E; Carnot F; Zylberberg H; Franco D; Capron F; Roskams T; Bréchot C
    Am J Pathol; 1999 Nov; 155(5):1525-33. PubMed ID: 10550309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.
    Wu H; Liu Y; Jiang XW; Li WF; Guo G; Gong JP; Ding X
    Tumour Biol; 2016 Oct; 37(10):13499-13508. PubMed ID: 27465555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma.
    Batmunkh E; Tátrai P; Szabó E; Lódi C; Holczbauer A; Páska C; Kupcsulik P; Kiss A; Schaff Z; Kovalszky I
    Hum Pathol; 2007 Oct; 38(10):1508-15. PubMed ID: 17640714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
    Zimmerman RL; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
    Sasaki M; Nakanuma Y; Ho SB; Kim YS
    Am J Clin Pathol; 1998 Mar; 109(3):302-8. PubMed ID: 9495202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vivo proton magnetic resonance spectroscopy of hepatocellular carcinoma and cholangiocarcinoma].
    Dong AS; Tian JM; Lu JP; Zuo CJ; Wang L; Wang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):151-4. PubMed ID: 19507591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 19. Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma.
    Fukase K; Ohtsuka H; Onogawa T; Oshio H; Ii T; Mutoh M; Katayose Y; Rikiyama T; Oikawa M; Motoi F; Egawa S; Abe T; Unno M
    Cancer Sci; 2008 Sep; 99(9):1785-92. PubMed ID: 18691339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), and combined HCC-CC (CHC) with each other based on microarray dataset.
    Wang L
    Tumour Biol; 2013 Jun; 34(3):1679-84. PubMed ID: 23532688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.